Company Registration No. 05169215 (England and Wales)
COVISION MEDICAL TECHNOLOGIES LIMITED
Unaudited accounts
for the year ended 31 December 2023
COVISION MEDICAL TECHNOLOGIES LIMITED
Unaudited accounts
Contents
COVISION MEDICAL TECHNOLOGIES LIMITED
Company Information
for the year ended 31 December 2023
Directors
DAYIBASI, Ugur
OZKAN, Mehmet
Company Number
05169215 (England and Wales)
Registered Office
42 BROOK STREET
OFFICE: 3.08
LONDON
W1K 5DB
ENGLAND
COVISION MEDICAL TECHNOLOGIES LIMITED
Statement of financial position
as at 31 December 2023
Investments
584,503
584,503
Cash at bank and in hand
11,837
17,853
Creditors: amounts falling due within one year
(48,669)
(87,097)
Net current assets
652,861
792,192
Net assets
1,237,364
1,376,695
Called up share capital
1,500,000
1,500,000
Profit and loss account
(262,636)
(123,305)
Shareholders' funds
1,237,364
1,376,695
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 2 September 2024 and were signed on its behalf by
DAYIBASI, Ugur
Director
Company Registration No. 05169215
COVISION MEDICAL TECHNOLOGIES LIMITED
Notes to the Accounts
for the year ended 31 December 2023
COVISION MEDICAL TECHNOLOGIES LIMITED is a private company, limited by shares, registered in England and Wales, registration number 05169215. The registered office is 42 BROOK STREET, OFFICE: 3.08, LONDON, W1K 5DB, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Investments in subsidiaries are measured at cost less accumulated impairment.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment.
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount
and are recognised in profit or loss.
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Plant & machinery
At 31 December 2023
29,422
At 31 December 2023
29,422
COVISION MEDICAL TECHNOLOGIES LIMITED
Notes to the Accounts
for the year ended 31 December 2023
5
Investments
Subsidiary undertakings
Valuation at 1 January 2023
584,503
Valuation at 31 December 2023
584,503
The company holds 100% of the ordinary share capital of Covision Medical Technologies Sanayi, a company registered in Turkey.
The company has taken the exemption from preparing consolidated financial statements as applicable under the small companies regime.
Amounts falling due within one year
Trade debtors
504,230
649,218
Amounts falling due after more than one year
Amounts due from group undertakings etc.
154,981
154,981
7
Creditors: amounts falling due within one year
2023
2022
Trade creditors
48,659
85,741
Taxes and social security
1
464
8
Average number of employees
During the year the average number of employees was 3 (2022: 3).